Dechra Pharmaceuticals PLC — Board/Management Information 2018

Dec 17, 2018

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6009K

Dechra Pharmaceuticals PLC

17 December 2018

17 December 2018

Dechra® Pharmaceuticals PLC

(Dechra, Company or the Group)

Appointment of Lisa Bright as Non-Executive Director of Dechra Pharmaceuticals PLC

Dechra is pleased to announce that, with effect from I February 2019, Lisa Bright will take up a new position as a Non-Executive Director of the Company.

Lisa's appointment brings skills to the Board in strategic and operational leadership in global market leading pharmaceutical and emerging biotech companies gained over her 25 year career in the industry.

Lisa is currently President International, and previously Chief Commercial and Corporate Affairs Officer of Intercept Pharmaceuticals, Inc, a global biopharmaceutical company focused on the development and commercialisation of novel therapeutics.  Previously Lisa held various Vice President roles at Gilead Sciences, Inc and GlaxoSmithKline plc, in Regional General Management, Government Affairs, and sales and marketing. Lisa is also a Non-Executive Director at Ascendis Pharma.

Commenting on the appointment Tony Rice, Chairman, Dechra Pharmaceuticals said:

"On behalf of the Board and all stakeholders I am delighted to welcome Lisa to Dechra.  She brings significant healthcare sector experience and strong inter-personal skills which will be invaluable as we continue our international expansion strategy and develop our employee engagement interaction."

There are no other disclosures to be made in respect of Lisa Bright, pursuant to Listing Rule 9.6.13R.

Enquiries to:
Dechra Pharmaceuticals PLC
Ian Page, Chief Executive Officer
Office:  +44 (0) 1606 814 730
e-mail: corporate.enquiries@dechra.com
TooleyStreet Communications Ltd
Fiona Tooley, Director Mobile: +44 (0) 7785 703 523 e-mail: fiona@tooleystreet.com

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and relates products business.  Our expertise is in the development, manufacture and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. 

For more information please visit: www.dechra.com

Stock Code: Full Listing (Pharmaceuticals): DPH

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BOAFFMFDMFASEEE